HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease.

AuthorsP J van Genderen, W Terpstra, J J Michiels, L Kapteijn, H H van Vliet
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 73 Issue 5 Pg. 891-2 (May 1995) ISSN: 0340-6245 [Print] Germany
PMID7482422 (Publication Type: Case Reports, Letter)
Chemical References
  • Autoantibodies
  • Immunoglobulin G
  • Immunoglobulins, Intravenous
  • von Willebrand Factor
Topics
  • Adult
  • Autoantibodies (immunology)
  • Autoimmune Diseases (metabolism, therapy)
  • Female
  • Hematoma (etiology)
  • Humans
  • Immunoglobulin G (immunology)
  • Immunoglobulins, Intravenous (pharmacology, therapeutic use)
  • Metabolic Clearance Rate
  • von Willebrand Diseases (metabolism, therapy)
  • von Willebrand Factor (metabolism, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: